Association Between Long-Term Metformin Use and Risk of Open-Angle Glaucoma in Patients With Diabetes Mellitus.

IF 2 4区 医学 Q2 OPHTHALMOLOGY
Shiang-Wen Huang, Yung-Rung Lai, Yih Yang, Shuo-Yan Gau, Ning-Jen Chung, Tung-Han Tsai, Kuang-Hua Huang, Chien-Ying Lee
{"title":"Association Between Long-Term Metformin Use and Risk of Open-Angle Glaucoma in Patients With Diabetes Mellitus.","authors":"Shiang-Wen Huang, Yung-Rung Lai, Yih Yang, Shuo-Yan Gau, Ning-Jen Chung, Tung-Han Tsai, Kuang-Hua Huang, Chien-Ying Lee","doi":"10.1097/IJG.0000000000002597","DOIUrl":null,"url":null,"abstract":"<p><strong>Prcis: </strong>Metformin use wasn't dose-dependently linked to open-angle glaucoma. Lower doses showed a protective effect, while higher doses had no significant impact.</p><p><strong>Purpose: </strong>The present study examined the enigmatic relationship between long-term metformin use and the risk of developing open-angle glaucoma (OAG) in patients with diabetes mellitus (DM). Additionally, we questioned whether metformin use affects the risk of OAG in a dose-dependent manner.</p><p><strong>Methods: </strong>This research was a retrospective cohort study using a nationally representative database established by the Health and Welfare Data Science Center of the Ministry of Health and Welfare, Taiwan, ROC. Patients diagnosed with new-onset DM between 2002 and 2013 were divided into two groups: a metformin-treated group and a sulfonylureas-treated group. The aim of our investigation is to evaluate the risk of OAG after a 5-year follow-up period. Using the Cox proportional hazard model, researchers estimated the risk of OAG in correlation with metformin treatment by the cumulative defined daily dose (cDDD), after adjusting for several key risk factors such as sex, age, income, urbanization level, diabetes severity, and various comorbidities.</p><p><strong>Result: </strong>A total of 2,102 patients (0.29%) developed OAG after 5 years of being diagnosed with DM. Among patients treated with metformin, the incidence rates of OAG were 0.27%, 0.27%, 0.29%, and 0.33% with cDDDs of<30, 30-120, 120-240, and >240, respectively. Following adjustments for relevant variables, patients who received metformin treatment at cDDDs of <30, 30-120, 120-240, and >240 exhibited HRs of 0.81 (95% CI=0.71-0.92), 0.83 (95% CI=0.74-0.93), 0.90 (95% CI=0.79-1.03), and 1.03 (95% CI=0.82-1.29), respectively, compared with those treated with sulfonylureas.</p><p><strong>Conclusion: </strong>Our findings suggest a moderate protective effect on the risk of open-angle glaucoma at lower cumulative metformin dosages. A dose-dependent effect was not observed.</p>","PeriodicalId":15938,"journal":{"name":"Journal of Glaucoma","volume":" ","pages":""},"PeriodicalIF":2.0000,"publicationDate":"2025-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Glaucoma","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/IJG.0000000000002597","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Prcis: Metformin use wasn't dose-dependently linked to open-angle glaucoma. Lower doses showed a protective effect, while higher doses had no significant impact.

Purpose: The present study examined the enigmatic relationship between long-term metformin use and the risk of developing open-angle glaucoma (OAG) in patients with diabetes mellitus (DM). Additionally, we questioned whether metformin use affects the risk of OAG in a dose-dependent manner.

Methods: This research was a retrospective cohort study using a nationally representative database established by the Health and Welfare Data Science Center of the Ministry of Health and Welfare, Taiwan, ROC. Patients diagnosed with new-onset DM between 2002 and 2013 were divided into two groups: a metformin-treated group and a sulfonylureas-treated group. The aim of our investigation is to evaluate the risk of OAG after a 5-year follow-up period. Using the Cox proportional hazard model, researchers estimated the risk of OAG in correlation with metformin treatment by the cumulative defined daily dose (cDDD), after adjusting for several key risk factors such as sex, age, income, urbanization level, diabetes severity, and various comorbidities.

Result: A total of 2,102 patients (0.29%) developed OAG after 5 years of being diagnosed with DM. Among patients treated with metformin, the incidence rates of OAG were 0.27%, 0.27%, 0.29%, and 0.33% with cDDDs of<30, 30-120, 120-240, and >240, respectively. Following adjustments for relevant variables, patients who received metformin treatment at cDDDs of <30, 30-120, 120-240, and >240 exhibited HRs of 0.81 (95% CI=0.71-0.92), 0.83 (95% CI=0.74-0.93), 0.90 (95% CI=0.79-1.03), and 1.03 (95% CI=0.82-1.29), respectively, compared with those treated with sulfonylureas.

Conclusion: Our findings suggest a moderate protective effect on the risk of open-angle glaucoma at lower cumulative metformin dosages. A dose-dependent effect was not observed.

糖尿病患者长期使用二甲双胍与开角型青光眼风险的关系
实践:二甲双胍的使用与开角型青光眼没有剂量依赖关系。低剂量显示出保护作用,而高剂量则没有显著影响。目的:本研究探讨长期使用二甲双胍与糖尿病(DM)患者发生开角型青光眼(OAG)风险之间的神秘关系。此外,我们质疑二甲双胍的使用是否以剂量依赖的方式影响OAG的风险。方法:本研究采用回顾性队列研究,采用中华民国卫生福利部卫生福利数据科学中心建立的具有全国代表性的数据库。2002年至2013年间诊断为新发糖尿病的患者分为两组:二甲双胍治疗组和磺脲嘧啶治疗组。我们调查的目的是在5年的随访期后评估OAG的风险。使用Cox比例风险模型,在调整了性别、年龄、收入、城市化水平、糖尿病严重程度和各种合并症等几个关键风险因素后,研究人员通过累积定义日剂量(cDDD)估计了OAG风险与二甲双胍治疗的相关性。结果:共2102例患者(0.29%)在确诊为DM的5年后发生OAG,在二甲双胍治疗的患者中,OAG的发生率分别为0.27%、0.27%、0.29%和0.33%,cDDDs分别为240。在对相关变量进行调整后,与磺脲类药物治疗的患者相比,接受cDDDs为240的二甲双胍治疗的患者的hr分别为0.81 (95% CI=0.71-0.92)、0.83 (95% CI=0.74-0.93)、0.90 (95% CI=0.79-1.03)和1.03 (95% CI=0.82-1.29)。结论:我们的研究结果表明,较低的二甲双胍累积剂量对开角型青光眼的风险有中等程度的保护作用。未观察到剂量依赖性效应。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Glaucoma
Journal of Glaucoma 医学-眼科学
CiteScore
4.20
自引率
10.00%
发文量
330
审稿时长
4-8 weeks
期刊介绍: The Journal of Glaucoma is a peer reviewed journal addressing the spectrum of issues affecting definition, diagnosis, and management of glaucoma and providing a forum for lively and stimulating discussion of clinical, scientific, and socioeconomic factors affecting care of glaucoma patients.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信